標(biāo)題: Titlebook: Antidepressants; From Biogenic Amines Matthew Macaluso,Sheldon H. Preskorn Book 2019 Springer Nature Switzerland AG 2019 Mood disorders.Tre [打印本頁] 作者: BULB 時間: 2025-3-21 16:54
書目名稱Antidepressants影響因子(影響力)
書目名稱Antidepressants影響因子(影響力)學(xué)科排名
書目名稱Antidepressants網(wǎng)絡(luò)公開度
書目名稱Antidepressants網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Antidepressants被引頻次
書目名稱Antidepressants被引頻次學(xué)科排名
書目名稱Antidepressants年度引用
書目名稱Antidepressants年度引用學(xué)科排名
書目名稱Antidepressants讀者反饋
書目名稱Antidepressants讀者反饋學(xué)科排名
作者: 水獺 時間: 2025-3-21 23:53 作者: agitate 時間: 2025-3-22 01:49
Einstieg in die Wirtschaftsmathematikclude patient retention and relapse, and longer-term follow-up. The chapter discusses the use of measurement-based care for delivering high-quality care, describes “treatment-resistant” depression and discusses its implications for clinical practice, and discusses the contributions of STAR*D to patient-oriented research and patient care.作者: VAN 時間: 2025-3-22 05:10
Tricyclic Antidepressants and Monoamine Oxidase Inhibitors: Are They Too Old for a New Look?, to the newer classes of antidepressants. Finally, we argue that TCAs, and particularly MAOIs, should continue to play an important role in the modern treatment of depression, especially in the treatment-resistant patient.作者: 討好美人 時間: 2025-3-22 09:40
Clinical Implications of the STAR*D Trial,clude patient retention and relapse, and longer-term follow-up. The chapter discusses the use of measurement-based care for delivering high-quality care, describes “treatment-resistant” depression and discusses its implications for clinical practice, and discusses the contributions of STAR*D to patient-oriented research and patient care.作者: ACME 時間: 2025-3-22 16:25
,Implikationen für den Markteintritt, cycle, pregnancy, and menopause also contribute to differences in depression and effective antidepressant use in women. Finally, it is important to consider potential interactions between antidepressant drugs and medications specifically used by women (oral contraceptives, tamoxifen, and estrogen).作者: justify 時間: 2025-3-22 17:38
https://doi.org/10.1007/978-3-642-85450-7 efficacy evidence and the concern for potential harm. This chapter reviews the current data concerning the use of traditional antidepressants in bipolar disorder, and the current expert treatment guideline recommendations for their use.作者: 描述 時間: 2025-3-22 22:30 作者: FISC 時間: 2025-3-23 02:43
The Use of Antidepressants in Bipolar Depression, efficacy evidence and the concern for potential harm. This chapter reviews the current data concerning the use of traditional antidepressants in bipolar disorder, and the current expert treatment guideline recommendations for their use.作者: 解脫 時間: 2025-3-23 06:28
Einstieg in die beweisorientierte Mathematik but differ in terms of pharmacokinetics and effects on CYP450 enzymes, which is detailed in this chapter. Further information will be provided regarding safety, clinical indications/uses, and dosing recommendations.作者: 落葉劑 時間: 2025-3-23 11:44
Selective Serotonin Reuptake Inhibitors, but differ in terms of pharmacokinetics and effects on CYP450 enzymes, which is detailed in this chapter. Further information will be provided regarding safety, clinical indications/uses, and dosing recommendations.作者: Memorial 時間: 2025-3-23 14:29 作者: 分發(fā) 時間: 2025-3-23 18:45 作者: 套索 時間: 2025-3-24 02:09
Clinical Implications of the STAR*D Trial,study and selected ancillary studies appended to the primary trial. The chapter describes the participants, their recruitment and treatment, and the study design, primary outcomes, and clinically informative results. In particular, the chapter describes acute phase response and remission rates from 作者: 遷移 時間: 2025-3-24 05:36 作者: 排出 時間: 2025-3-24 08:46 作者: inundate 時間: 2025-3-24 11:32 作者: Muscularis 時間: 2025-3-24 17:04
Serotonin and Norepinephrine Reuptake Inhibitors,e 5-HT and NE transporters with varying levels of potency and binding affinity ratios. Unlike the selective serotonin (5-HT) reuptake inhibitors (SSRIs), most of these antidepressants have an ascending rather than a flat dose–response curve. The chapter provides a brief review of the chemistry, phar作者: Inferior 時間: 2025-3-24 19:30
Neurostimulation Therapies,of adequate trials of medication and psychotherapy. Neuromodulation treatments offer a qualitatively different modality of treatment that can frequently prove efficacious in these treatment-refractory patients. The field of neuromodulation focuses on the use of electrical/electromagnetic energy, bot作者: 不愿 時間: 2025-3-25 00:18
Current Role of Herbal and Natural Preparations,not responded to and/or had adverse effects from standard therapies, herbal and natural medications represent a potentially valuable alternative. This chapter will review several natural remedies used in the treatment of depression. Specific remedies covered include St. John’s wort (SJW), S-adenosyl作者: 粗糙濫制 時間: 2025-3-25 03:38
Role of Inflammation in Depression and Treatment Implications,e needed to identify pathophysiologic pathways and neurobiological targets for the development of novel treatment strategies. In this regard, recent evidence suggests that inflammation may contribute to symptoms relevant to a number of psychiatric disorders and particularly depression. Numerous stud作者: 凝乳 時間: 2025-3-25 09:58 作者: 暫停,間歇 時間: 2025-3-25 14:49 作者: 符合規(guī)定 時間: 2025-3-25 19:37
Other Antidepressants,cluding bupropion, mirtazapine, trazodone, vortioxetine, and vilazodone. These medications do not belong to one of the previously featured classes of antidepressants discussed in the preceding chapters. Each medication featured in this chapter has a unique structure and properties that target divers作者: 否決 時間: 2025-3-25 23:54 作者: Favorable 時間: 2025-3-26 02:39
Treatment of Depression in Women,cietal factors may contribute to women’s increased likelihood of depression. Pharmacological research targeting depression has historically excluded women, leading to a knowledge gap regarding effective antidepressant treatment in women. Antidepressant pharmacokinetics and pharmacodynamics are clear作者: 使增至最大 時間: 2025-3-26 08:13 作者: BRINK 時間: 2025-3-26 10:29 作者: Daily-Value 時間: 2025-3-26 15:28
https://doi.org/10.1007/978-3-322-91880-2particularly emphasizes the historical evolution of the pertinent diagnostic constructs and the prognostic import both of the various diagnostic groupings and of the individual symptoms and symptom clusters.作者: Psa617 時間: 2025-3-26 20:44
Einstieg in die Wirtschaftsmathematik used clinically and have been widely available for over half a century. From the 1950s to the 1980s, these two classes of antidepressants were the sole antidepressant tools available to psychiatrists. With the advent of the selective serotonin reuptake inhibitors (SSRIs) in the 1980s and 1990s, the作者: Aerophagia 時間: 2025-3-26 22:36
Einstieg in die Wirtschaftsmathematikstudy and selected ancillary studies appended to the primary trial. The chapter describes the participants, their recruitment and treatment, and the study design, primary outcomes, and clinically informative results. In particular, the chapter describes acute phase response and remission rates from 作者: EWER 時間: 2025-3-27 02:16 作者: Fallibility 時間: 2025-3-27 06:33 作者: peak-flow 時間: 2025-3-27 13:29 作者: Amylase 時間: 2025-3-27 15:14 作者: plasma-cells 時間: 2025-3-27 19:16 作者: Needlework 時間: 2025-3-28 01:06
Grundlagen der stochastischen Analysis,not responded to and/or had adverse effects from standard therapies, herbal and natural medications represent a potentially valuable alternative. This chapter will review several natural remedies used in the treatment of depression. Specific remedies covered include St. John’s wort (SJW), S-adenosyl作者: 一再遛 時間: 2025-3-28 02:54
https://doi.org/10.1007/978-3-322-84364-7e needed to identify pathophysiologic pathways and neurobiological targets for the development of novel treatment strategies. In this regard, recent evidence suggests that inflammation may contribute to symptoms relevant to a number of psychiatric disorders and particularly depression. Numerous stud作者: 卵石 時間: 2025-3-28 08:06
Skizze: Ablauf des Studienmodells,agonists are currently being actively investigated as a treatment for these patients. Ketamine is the most widely studied of the compounds. A brief infusion of a low dose of this agent produces rapid improvement in depressive symptoms that lasts for several days. The improvement occurs after the age作者: STELL 時間: 2025-3-28 13:37
Einsturzh?ufigkeit von Bauwerkensent and then looks forward to the future. It begins with the chance discovery drugs and then moves to through their rational refinement using structure activity relationships to narrow the pharmacological actions of the drugs to those mediating their antidepressant effects and eliminating the effec作者: 按等級 時間: 2025-3-28 17:25 作者: 半圓鑿 時間: 2025-3-28 20:48 作者: 遺棄 時間: 2025-3-29 01:15 作者: COM 時間: 2025-3-29 05:36 作者: Contracture 時間: 2025-3-29 07:20
https://doi.org/10.1007/978-3-642-85450-7 for its treatment, only one of which includes a traditional antidepressant (olanzapine-fluoxetine combination), despite studies that demonstrate traditional antidepressants are one of the most commonly prescribed class of medications for bipolar patients in a depressive episode. While traditional a作者: growth-factor 時間: 2025-3-29 13:28 作者: 項目 時間: 2025-3-29 18:57
https://doi.org/10.1007/978-3-322-91880-2particularly emphasizes the historical evolution of the pertinent diagnostic constructs and the prognostic import both of the various diagnostic groupings and of the individual symptoms and symptom clusters.作者: 喪失 時間: 2025-3-29 20:51 作者: 實施生效 時間: 2025-3-30 02:05
https://doi.org/10.1007/978-3-030-10949-3Mood disorders; Treatment resistant depression; Novel mechanism of action drugs; Psychopharmacology; Cli作者: Fibrillation 時間: 2025-3-30 07:25 作者: commensurate 時間: 2025-3-30 10:16 作者: PANEL 時間: 2025-3-30 12:36 作者: 喊叫 時間: 2025-3-30 19:48
Impact, Diagnosis, Phenomenology, and Biology,particularly emphasizes the historical evolution of the pertinent diagnostic constructs and the prognostic import both of the various diagnostic groupings and of the individual symptoms and symptom clusters.作者: enmesh 時間: 2025-3-31 00:44 作者: 無能力之人 時間: 2025-3-31 01:44
Pharmacogenomics and Biomarkers of Depression,ion of one antidepressant over another. Among all currently available biomarkers, C-reactive protein (CRP) appears to be the most promising and pragmatic choice. Low CRP (<1?mg/L) in patients with MDD predicts better response to escitalopram while higher levels are associated with better response to作者: 植物茂盛 時間: 2025-3-31 06:43 作者: nugatory 時間: 2025-3-31 12:22 作者: FLUSH 時間: 2025-3-31 14:58
Neurostimulation Therapies,ly three such treatments are currently approved by the United States Food and Drug Administration (FDA) for the treatment of major depressive disorder: electroconvulsive therapy (ECT), vagus nerve stimulation (VNS), and repetitive transcranial magnetic stimulation (rTMS). Additionally, numerous othe作者: 避開 時間: 2025-3-31 18:41
Current Role of Herbal and Natural Preparations,e treatments remain unanswered and much work needs to be done before we determine their place in the psychiatric armamentarium, we believe that this chapter will give psychiatrists a good perspective on the pros and cons of herbal and natural antidepressants as part of the pharmacological armamentar作者: 友好 時間: 2025-3-31 22:27
Role of Inflammation in Depression and Treatment Implications,ional antidepressant therapies. Recent developments in our ability to understand and measure the effects of inflammation on the brain in patients have opened new doors for the testing of novel treatment strategies that target the immune system or its consequences on neurotransmitter systems. Such re作者: Compassionate 時間: 2025-4-1 04:17
NMDA Antagonists for Treatment-Resistant Depression,ponse 8?weeks after the infusion. As this was a pilot study, additional work is needed to confirm and extend this finding. Nitrous oxide also has had positive results. Of the other investigational agents, CERC-301 and rapastinel remain in clinical development. When careful monitoring of neuropsychia
